Mineral-bone metabolism markers in young hemodialysis patients

Clinical Biochemistry

Volumn 44, Issue 17-18, 2011, Pages 1425-1428

  Osorio, Alvaro ^a   Ortega, Esperanza ^b,c   Torres, Jesús M ^b,c   Sanchez, Pilar ^b   Ruiz Requena, Estrella ^b  

^a Virgen de la Luz Hospital   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Bone metabolism; Hyperparathyroidism; OPG; Osteocalcin; RANKL; Vitamin D; Young hemodialysis patients

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5B; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BONE SPECIFIC ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL DERIVATIVE; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHORUS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRAVASCULAR CALCIFICATION; HEMODIALYSIS PATIENT; HUMAN; MINERAL METABOLISM; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS;

ACID PHOSPHATASE; ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCIFEDIOL; CALCITRIOL; CALCIUM; CASE-CONTROL STUDIES; HUMANS; ISOENZYMES; KIDNEY FAILURE, CHRONIC; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHORUS; PROGNOSIS; RANK LIGAND; RENAL DIALYSIS; YOUNG ADULT;

EID: 81555205823     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.08.1143     Document Type: Article

References (34)

1. Drüeke T. Renal osteodystrophy: management of hyperphosphataemia. Nephrol Dial Transplant 2000, 15:32-33.
2. Moe S., Drueke T., Cunninghan J., Goodman W., Martin K., Olgaard K., et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 2006, 69:1945-1953.
3. Moe S.M., Drueke T., Lamiere N., Eknoyan G. Chronic Kidney disease-mineral-bone disorder: a new paradigm. Adv Kidney Dis 2007, 14:3-12.
4. Gal-Moscovici A., Sprague S.M. Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis 2007, 14:27-36.
5. Roob J.M., Rabold T., Hayn T., Khoschsorur G., Resch U., Holzer H., et al. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD. Kidney Int 2001, 78:128-136.
6. Van Kuijk J.P., Flu W.J., Chonchol M., Welten G.M., Verhagen H.J., Bax J.J., et al. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant 2010, 25:1882-1888.
7. Junguers P., Massy Z.A., Khoa T.N., Fumeron C., Labrunie M., Lacour B., et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997, 12:2597-2602.
8. Schwarz U., Buzello M., Ritz E., Stein G., Raabe G., Wiest G., et al. Morphology of coronary atherosclerotic cardiovascular accidents lesions in patients with end-stage renal-failure. Nephrol Dial Transplant 2000, 15:218-223.
9. Dellegrottaglie Santo, Sanz Javier, Rajagopalan Sanjay Vascular calcification in patients with chronic kidney disease. Blood Purif 2006, 24:56-62.
10. Kestenbaum B., Belozeroff V. Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest 2007, 37:607-622.
11. Bostrom K., Watson K.E., Horn S., Wortham C., Herman I.M., Demer L.L. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993, 91:1800-1809.
12. Fitzpatrick L.A., Severson A., Edwards W.D., Imgram R.T. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994, 94:1597-1604.
13. Moe S.M., O'Neill K.D., Duan D., Ahmed S., Chem N.X., Leapman S.B., et al. Medical artery calcification in ESRD patients is associated with deposition of bone matriz proteins. Kidney Int 2002, 61:638-647.
14. El Abbadi M., Giachelli C.M. Mechanism of vascular calcification. Adv Chronic Kidney Dis 2007, 14:54-66.
15. Sananhan C.M., Cary N.R., Metcalfe J.C., Weisberg P.L. High expression of genes for calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002, 61:638-647.
16. Junyent M., Martinez M., Borras M., Bertriu A., Coll B., Craver L., et al. Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project. Nefrologia 2010, 30:119-126.
17. Sigrist M.K., Levin A., McIntyre C.W. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant 2009, 24:3157-3162.
18. Doumouchtsis K.K., Kostakis A.I., Doumouchtsis S.K., Tziamalis M.P., Tsigris C., Kostaki M.A., et al. sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients. J Endocrinol Invest 2007, 30:762-766.
19. Nishiura R., Fujimoto S., Sato Y., Yamada K., Hisanaga S., Hara S., et al. Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. Am J Nephrol 2009, 29:257-263.
20. Avbersek-Luznik I., Balon B.P., Rus I., Marc J. Increased bone resorption in HD patients:is it caused by elevated RANKL synthesis?. Nephrol Dial Transplant 2005, 20:566-570.
21. Nakamichi Y., Udagawa N., Kobayashi Y., Nakamura M., Yamamoto Y., Yamashita T., et al. Osteoprotegerin reduces the serum level of receptor activator of NF_ kappa B ligand derived from osteoblasts. J Immunol 2007, 178:192-200.
22. Nishio S., Hayashi S., Yoshihara H., Kobayagawa H. Clinical evaluation of osteocalcin in chronic hemodialysis patients. Hinyokika Kiyo 1989, 35:1839-1845.
23. Shidara K., Inaba M., Okuno S., Yamada S., Kumeda Y., Imanishi Y., et al. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int 2008, 82:278-287.
24. Panizo S., Cardus A., Encinas M., Parisi E., Valcheva P., López-Ongil S., et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 2009, 104:1041-1048.
25. Coen G., Ballanti P., Balducci A., Calbria S., Fischer M.S., Jankovic L., et al. Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 2002, 17:233-238.
26. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hecberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7:439-443.
27. Coburn J.W., Koppel M.H., Brickman A.S., Massry S.G. Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 1973, 3:264-272.
28. Michaud J., Naud J., Ouimet D., Demers C., Petit J.L., Leblond F.A., et al. Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 2010, 21:1488-1497.
29. Shroff R., Egerton M., Bridel M., Shah V., Donald A.E., Cole T.J., et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008, 19:1239-1246.
30. Taskapan H., Wei M., Oreopoulos D.G. 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 2006, 38:323-329.
31. Ghazali A., Fardellone P., Pruna A., Atik A., Achard J.M., Oprisiu R., et al. Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?. Kidney Int 1999, 55:2169-2177.
32. Coll B., Betriu A., Martínez-Alonso M., Amoedo M.L., Arcidiacono M.V., Borras M., et al. Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. Clin J Am Soc Nephrol 2011, 6:303-310.
33. Adragao T, Pires A, Branco P, Castro R, Oliveira A, Nogueira C, Bordalo J, Curto JD, Prata MM. Ankle-brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 2011;doi:. http://doi:10.1093/ndt/gfr233.
34. Honkanen E., Kauppila L., Wikström B., Rensma P.L., Krzesinski J.M., Aasarod K., et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008, 23:4009-4015.